Newsroom

Innovative single-dose topical treatment proven to safely and effectively treat clinical signs associated with otitis externa in dogs MADISON, N.J., USA, October 24, 2022– MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the European Medicines Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) issued a […]

Read more

Through its Afya Program, MSD Animal Health Is Committed to the United Against Rabies collaboration’s “Zero by 30” Rabies Elimination Goal MADISON, N.J., Sept. 28, 2022 – MSD Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE: MRK), announced on World Rabies Day that it has now donated more than five million […]

Read more

Digital swine traceability solution tracks swine throughout their lifecycle Investment complements MSD Animal Health’s broad portfolio of veterinary pharmaceuticals, vaccines and technology solutions MADISON, N.J., Sept. 27, 2022 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced that it has completed a minority investment in LeeO Precision Farming […]

Read more

Virtual fencing system provides advanced technology to cattle producers and ranchers to manage natural resources more effectively Complements MSD Animal Health’s broad portfolio of veterinary pharmaceuticals, vaccines and animal intelligence solutions MADISON, N.J., Sept. 22, 2022 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced that it has […]

Read more

Preliminary results of field study found 73% of farms tested positive for BCoV BCoV associated with increased risk for Bovine Respiratory Disease (BRD), one of the most common and costly diseases in calves Madison, N.J., Sept. 5, 2022– MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today preliminary […]

Read more

Company to present a record 80+ abstracts at World Buiatrics Congress Data include first-ever field study evaluating prevalence of bovine coronavirus (BCoV) in Europe Madison, N.J., Aug. 29, 2022– MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today that a record of more than 81 abstracts with support […]

Read more

DNA TRACEBACK® Fisheries platform supports sustainability helping to determine catch limits across multiple fish MADISON, N.J., May 25, 2022 – MSD Animal Health, a division of Merck & Co., Inc., Rahway,  N.J., USA (NYSE:MRK), announced today the launch of the DNA TRACEBACK® Fisheries platform, a new DNA-based analytical tool which helps governments and fishery agencies […]

Read more

Robert Kelly brings deep expertise and knowledge of animal health industry MADISON, N.J., May 9, 2022 – MSD Animal Health, a division of Merck & Co., Inc., Rahway,  N.J., USA (NYSE:MRK), announced today Robert (Rob) Kelly as the new leader of the company’s Europe, Russia, Africa and Middle East (EURAM) Region, beginning June 2022. Rob […]

Read more

MADISON, N.J., April 26, 2022 – MSD Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE:MRK), today launched its line of Hyper InfusiO2n solutions designed to improve fish attraction and passage at dam facilities by efficiently supplying stable, dissolved oxygen throughout fish passageways. Millions of fish migrate to their native habitats […]

Read more